Global Radiodermatitis Treatment Market Forecast to 2023: Dominated by 3M, Acelity, ConvaTec Group, Mlnlycke Health Care, and Smith & Nephew - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 21, 2019--
The “Global Radiodermatitis Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The radiodermatitis treatment market will register a CAGR of over 4% by 2023.
Several rising initiatives by research institutes are impacting the radiodermatitis treatment market growth during the forecast period. Existing vendors are further striving to evaluate the therapeutic efficacy of a wide range of radiodermatitis treatment products for leveraging their product portfolio.
Researchers from different universities are using low-intensity laser therapy in breast cancer patients for preventing and controlling the symptoms of this health condition. As a result, initiatives by several research institutes will lead to the radiodermatitis treatment market growth during the forecast period.
The rising number of public and private healthcare organizations
Promoting awareness about radiodermatitis diagnosis and treatment and increasing the adoption of radiodermatitis products. This will drive the growth of the market during the forecast period.
Advent of novel radiation equipment with fewer side-effects
The global radiodermatitis treatment market is currently witnessing the advent of novel radiation equipment with fewer side-effects, leading to a decrease in demand for radiodermatitis drugs, thereby hindering the market growth.
The market appears to be moderately fragmented. Several vendors are focusing on the concept of moisture therapy, which involves moisturizing the wound area to promote natural cell repair while giving the injured cells sufficient time to recover.
This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: DISEASE OVERVIEW
PART 06: FIVE FORCES ANALYSIS
PART 07: PIPELINE
PART 08: MARKET SEGMENTATION BY PRODUCT
PART 09: CUSTOMER LANDSCAPE
PART 10: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
PART 11: GEOGRAPHIC LANDSCAPE
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
PART 14: MARKET TRENDS
PART 15: VENDOR LANDSCAPE
PART 16: VENDOR ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/p7aynt
View source version on businesswire.com:https://www.businesswire.com/news/home/20190521005814/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Dermatological Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/21/2019 01:04 PM/DISC: 05/21/2019 01:04 PM